N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats

Hearing Research

Volumn 267, Issue 1-2, 2010, Pages 71-77

  Wu, Hung Pin ^a,b,c,d   Hsu, Chuan Jen ^e   Cheng, Tsun Jen ^a,e   Guo, Yueliang Leon ^a,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELECTROCOCHLEOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; MALE; NOISE; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ANIMAL; BODY WEIGHT; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; NOISE INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GLUTATHIONE; HAIR CELLS, AUDITORY, OUTER; HEARING LOSS, NOISE-INDUCED; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 77954176142     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2010.03.082     Document Type: Article

References (44)

1. Bielefeld E.C., Kopke R.D., Jackson R.L., Coleman J.K., Liu J., Henderson D. Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration. Acta Otolaryngol. 2007, 127:914-919.
2. Borg E., Engstrom B. Noise level, inner hair cell damage, audiometric features, and equal-energy hypothesis. J. Acoust. Soc. Am. 1989, 86:1776-1782.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
4. Chen G.D., Fechter L.D. The relationship between noise-induced hearing loss and hair cell loss in rats. Hear. Res. 2003, 177:81-90.
5. Chen G.D., McWilliams M.L., Fechter L.D. Succinate dehydrogenase (SDH) activity in hair cells: a correlate for permanent threshold elevations. Hear. Res. 2000, 145:91-100.
6. Chen Y.S., Tseng F.Y., Liu T.C., Lin-Shiau S.Y., Hsu C.J. Involvement of nitric oxide generation in noise-induced temporary threshold shift in guinea pigs. Hear. Res. 2005, 203:94-100.
7. Clerici W.J., Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear. Res. 1996, 101:14-22.
8. Coleman J.K., Kopke R.D., Liu J., Ge X., Harper E.A., Jones G.E., Cater T.L., Jackson R.L. Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-l-carnitine. Hear. Res. 2007, 226:104-113.
9. Daniel E. Noise and hearing loss: a review. J. Sch. Health 2007, 77:225-231.
10. Engstrom B., Borg E. Cochlear morphology in relation to loss of behavioural, electrophysiological, and middle ear reflex thresholds after exposure to noise. Acta Otolaryngol. Suppl. 1983, 402:5-23.
11. Fechter L.D., Young J.S., Carlisle L. Potentiation of noise induced threshold shifts and hair cell loss by carbon monoxide. Hear. Res. 1988, 34:39-47.
12. Fechter L.D., Liu Y., Pearce T.A. Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig. Toxicol. Appl. Pharmacol. 1997, 142:47-55.
13. Fukushima H., Cureoglu S., Schachern P.A., Kusunoki T., Oktay M.F., Fukushima N., Paparella M.M., Harada T. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol. Head Neck Surg. 2005, 133:100-106.
14. Hodgson M.J., Talbott E., Helmkamp J.C., Kuller L.H. Diabetes, noise exposure, and hearing loss. J. Occup. Med. 1987, 29:576-579.
15. Hsu C.J., Liu T.C., Lin K.N. Effect of acoustic trauma on cytochrome oxidase activity in stria vascularis. ORL J. Otorhinolaryngol. Relat. Spec. 1998, 60:314-317.
16. Ishii E.K., Talbott E.O., Findlay R.C., D'Antonio J.A., Kuller L.H. Is NIDDM a risk factor for noise-induced hearing loss in an occupationally noise exposed cohort?. Sci. Total Environ. 1992, 127:155-165.
17. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
18. Kopke R., Allen K.A., Henderson D., Hoffer M., Frenz D., Van de Water T. A radical demise. Toxins and trauma share common pathways in hair cell death. Ann. N.Y. Acad. Sci. 1999, 884:171-191.
19. Kopke R.D., Coleman J.K., Liu J., Campbell K.C., Riffenburgh R.H. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss. Laryngoscope 2002, 112:1515-1532.
20. Kopke R.D., Jackson R.L., Coleman J.K., Liu J., Bielefeld E.C., Balough B.J. NAC for noise: from the bench top to the clinic. Hear. Res. 2007, 226:114-125.
21. Lataye R., Campo P. Combined effects of a simultaneous exposure to noise and toluene on hearing function. Neurotoxicol. Teratol. 1997, 19:373-382.
22. Lin C.D., Oshima T., Oda K., Yamauchi D., Tsai M.H., Kobayashi T. Ototoxic interaction of kanamycin and 3-nitropropionic acid. Acta Otolaryngol. 2008, 128:1280-1285.
23. Lynch E.D., Kil J. Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov. Today 2005, 10:1291-1298.
24. Mandel J.H., Luxenberg M. Diabetes and hearing loss. J. Occup. Med. 1988, 30:271-272.
25. Medina-Navarro R., Duran-Reyes G., Diaz-Flores M., Hicks J.J., Kumate J. Glucose-stimulated acrolein production from unsaturated fatty acids. Hum. Exp. Toxicol. 2004, 23:101-105.
26. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
27. Muller M. Frequency representation in the rat cochlea. Hear. Res. 1991, 51:247-254.
28. Niskar A.S., Kieszak S.M., Holmes A., Esteban E., Rubin C., Brody D.J. Prevalence of hearing loss among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey. JAMA 1998, 279:1071-1075.
29. Niskar A.S., Kieszak S.M., Holmes A.E., Esteban E., Rubin C., Brody D.J. Estimated prevalence of noise-induced hearing threshold shifts among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey, 1988-1994, United States. Pediatrics 2001, 108:40-43.
30. Ohlemiller K.K., Wright J.S., Dugan L.L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol. Neurootol. 1999, 4:229-236.
31. Rahman Q., Abidi P., Afaq F., Schiffmann D., Mossman B.T., Kamp D.W., Athar M. Glutathione redox system in oxidative lung injury. Crit. Rev. Toxicol. 1999, 29:543-568.
32. Santos M.S., Santos D.L., Palmeira C.M., Seica R., Moreno A.J., Oliveira C.R. Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab. Res. Rev. 2001, 17:223-230.
33. Shin A.H., Oh C.J., Park J.W. Glycation-induced inactivation of antioxidant enzymes and modulation of cellular redox status in lens cells. Arch. Pharm. Res. 2006, 29:577-581.
34. Smith T.L., Raynor E., Prazma J., Buenting J.E., Pillsbury H.C. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 1995, 105:236-240.
35. Tan A.L., Forbes J.M., Cooper M.E. AGE, RAGE, and ROS in diabetic nephropathy. Semin. Nephrol. 2007, 27:130-143.
36. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25:612-628.
37. Vincent A.M., Olzmann J.A., Brownlee M., Sivitz W.I., Russell J.W. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 2004, 53:726-734.
38. Vincent A.M., Edwards J.L., Sadidi M., Feldman E.L. The antioxidant response as a drug target in diabetic neuropathy. Curr. Drug Targets 2008, 9:94-100.
39. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., Feldman E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148:548-558.
40. Von Korff M., Katon W., Lin E.H., Simon G., Ciechanowski P., Ludman E., Oliver M., Rutter C., Young B. Work disability among individuals with diabetes. Diabetes Care 2005, 28:1326-1332.
41. Wassick K.H., Yonovitz A. Methyl mercury ototoxicity in mice determined by auditory brainstem responses. Acta Otolaryngol. 1985, 99:35-45.
42. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
43. Wu H.P., Cheng T.J., Tan C.T., Guo Y.L., Hsu C.J. Diabetes impairs recovery from noise-induced temporary hearing loss. Laryngoscope 2009, 119:1190-1194.
44. Yamane H., Nakai Y., Takayama M., Iguchi H., Nakagawa T., Kojima A. Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur. Arch. Otorhinolaryngol. 1995, 252:504-508.